Oncotelic Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Oncotelic Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 407M shares, a 2.29% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 407M +9.13M +2.29% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 407M +9.76M +2.46% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 400M +6.81M +1.73% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 399M +7.34M +1.87% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 398M +7.96M +2.04% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 398M +11.5M +2.98% Jun 30, 2023 10-Q 2023-08-18
Q1 2023 393M +14.2M +3.76% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 392M +16.6M +4.41% Dec 31, 2022 10-K 2024-04-12
Q3 2022 390M +17.6M +4.73% Sep 30, 2022 10-Q 2022-11-18
Q2 2022 386M +15.9M +4.31% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 379M +9.18M +2.49% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 375M +285M +314% Dec 31, 2021 10-K/A 2023-04-20
Q3 2021 373M +283M +316% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 370M +281M +318% Jun 30, 2021 10-Q 2021-08-20
Q1 2021 369M +281M +320% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 90.6M +6.53M +7.77% Dec 31, 2020 10-K 2022-04-15
Q3 2020 89.6M +6.13M +7.35% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 88.6M +5.13M +6.15% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 88M +46.6M +113% Mar 31, 2020 10-Q 2020-06-29
Q4 2019 84.1M +77.2M +1128% Dec 31, 2019 10-K 2021-04-15
Q3 2019 83.5M +42M +102% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 83.5M +42M +102% Jun 30, 2019 10-Q 2019-08-19
Q1 2019 41.4M +14.9M +56% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 6.84M -19.7M -74.2% Dec 31, 2018 10-K 2020-05-14
Q3 2018 41.4M +14.9M +56% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 41.4M +14.9M +56% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 26.5M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 26.5M 0 0% Dec 31, 2017 10-K 2019-04-10
Q3 2017 26.5M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 26.5M 0 0% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 26.5M 0 0% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 26.5M 0 0% Dec 31, 2016 10-K 2018-04-17
Q3 2016 26.5M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 26.5M 0 0% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 26.5M 0 0% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 26.5M +5.84M +28.2% Dec 31, 2015 10-K 2017-03-30
Q3 2015 26.5M +5.84M +28.2% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 26.5M +5.84M +28.2% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 26.5M +11.3M +73.6% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 20.7M +15.1M +271% Dec 31, 2014 10-K 2016-03-25
Q3 2014 20.7M +17.7M +590% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 20.7M +18.4M +810% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 15.3M +13.2M +637% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 5.59M +3.84M +220% Dec 31, 2013 10-K 2015-03-30
Q3 2013 3M -16.8M -84.8% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 2.27M -15.3M -87% Jun 30, 2013 10-Q/A 2013-10-18
Q1 2013 2.08M -14.1M -87.2% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 1.75M +481K +38% Dec 31, 2012 10-K 2014-03-20
Q3 2012 19.8M +4.99M +33.8% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 17.5M +5.86M +50.2% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 16.2M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 1.27M -4.24M -77% Dec 31, 2011 10-K 2013-03-15
Q3 2011 14.8M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 11.7M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 5.5M Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.